This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: Cisco, Office Depot, Pharmacyclics, Staples


Bonanza Creek (BCEI) was upgraded at Topeka Capital to buy from hold. Twelve-month price target is $68. Wattenberg acquisition should be highly accretive to earnings, Topeka Capital said.

Bio-Rad Laboratories (BIO) was downgraded to hold at TheStreet Ratings.

Cepheid (CPHD) was upgraded at Needham to buy from hold. Twelve-month price target is $50. More positive on the company, following meetings with management, Needham said.

Cisco (CSCO - Get Report) was upgraded at Deutsche Bank to buy from hold. Twelve-month price target is $30. See stronger-than-anticipated business ramp, Deutsche Bank said.

CIT Group (CIT) was downgraded to sell at TheStreet Ratings.

Guidewire (GWRE) was upgraded at Citigroup to neutral. Twelve-month price target is $43. Expectations have come in and company fundamentals are improving, Citigroup said.

Office Depot (ODP - Get Report) was upgraded at Goldman Sachs to buy from neutral. Twelve-month price target is $7. Company can likely exceed consensus earnings expectations, Goldman Sachs said.

Palo Alto (PANW) was upgraded at Nomura to buy from neutral. Twelve-month price target is $80. See fewer risks around the Juniper litigation, Nomura said.

Pharmacyclics (PCYC) was downgraded at RBC Capital to sector perform from outperform. Twelve-month price target is $95. Company is facing potential growth headwinds, RBC Capital said.

Staples (SPLS) was downgraded at Goldman Sachs to sell. Twelve-month price target is $11. Company is facing margin pressure, Goldman said.

Editor's note: To see analysts' stock comments and changes to price targets and earnings estimates, go to "Street Notes" which is available only to Real Money subscribers. To find out how to become a subscriber, please click here.

Follow TheStreet on Twitter and become a fan on Facebook.

>>Read More: Apple's 'Smart Home' Levels Android All Over Again

This article was written by a staff member of TheStreet.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
CSCO $27.49 0.00%
ODP $5.88 0.00%
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs